142 related articles for article (PubMed ID: 24463539)
1. Safety of combination therapy with milrinone and esmolol for heart protection during percutaneous coronary intervention in acute myocardial infarction.
Poh KK; Xu X; Chan MY; Lee CH; Tay EL; Low AF; Chan KH; Sia W; Tang LQ; Tan HC; Lui CY; Nguyen V; Fujise K; Huang MH
Eur J Clin Pharmacol; 2014 May; 70(5):527-30. PubMed ID: 24463539
[TBL] [Abstract][Full Text] [Related]
2. Heart protection by combination therapy with esmolol and milrinone at late-ischemia and early reperfusion.
Huang MH; Wu Y; Nguyen V; Rastogi S; McConnell BK; Wijaya C; Uretsky BF; Poh KK; Tan HC; Fujise K
Cardiovasc Drugs Ther; 2011 Jun; 25(3):223-32. PubMed ID: 21562974
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy with milrinone and esmolol for heart protection in patients with severe sepsis: a prospective, randomized trial.
Wang Z; Wu Q; Nie X; Guo J; Yang C
Clin Drug Investig; 2015 Nov; 35(11):707-16. PubMed ID: 26387030
[TBL] [Abstract][Full Text] [Related]
4. Intravenous esmolol is well tolerated in elderly patients with heart failure in the early phase of non-ST elevation myocardial infarction.
Koutouzis M; Nikolidakis S; Grigoriadis A; Koutsogeorgis D; Kyriakides ZS
Drugs Aging; 2006; 23(8):673-80. PubMed ID: 16964989
[TBL] [Abstract][Full Text] [Related]
5. Safety of esmolol in patients with acute myocardial infarction treated with thrombolytic therapy who had relative contraindications to beta-blocker therapy.
Mooss AN; Hilleman DE; Mohiuddin SM; Hunter CB
Ann Pharmacother; 1994 Jun; 28(6):701-3. PubMed ID: 7919552
[TBL] [Abstract][Full Text] [Related]
6. [Effects of Tongxinluo Capsule on Platelet Activating Factor, Vascular Endothelial Function, Blood Flow of Thrombolysis in Myocardial Infarction in Acute Myocardial Infarction Patients after Delayed Percutaneous Coronary Intervention].
Chen ZQ; Hong L; Wang H; Yin QL
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Apr; 36(4):415-20. PubMed ID: 27323611
[TBL] [Abstract][Full Text] [Related]
7. Reduction in myocardial infarct size by postconditioning in patients after percutaneous coronary intervention.
Yang XC; Liu Y; Wang LF; Cui L; Wang T; Ge YG; Wang HS; Li WM; Xu L; Ni ZH; Liu SH; Zhang L; Jia HM; Vinten-Johansen J; Zhao ZQ
J Invasive Cardiol; 2007 Oct; 19(10):424-30. PubMed ID: 17906344
[TBL] [Abstract][Full Text] [Related]
8. Randomized Control of Sympathetic Drive With Continuous Intravenous Esmolol in Patients With Acute ST-Segment Elevation Myocardial Infarction: The BEtA-Blocker Therapy in Acute Myocardial Infarction (BEAT-AMI) Trial.
Er F; Dahlem KM; Nia AM; Erdmann E; Waltenberger J; Hellmich M; Kuhr K; Le MT; Herrfurth T; Taghiyev Z; Biesenbach E; Yüksel D; Eran-Ergöknil A; Vanezi M; Caglayan E; Gassanov N
JACC Cardiovasc Interv; 2016 Feb; 9(3):231-240. PubMed ID: 26847114
[TBL] [Abstract][Full Text] [Related]
9. Effects of receipt of chronic statin therapy before the onset of acute myocardial infarction: a retrospective study in patients undergoing primary percutaneous coronary intervention.
Ishii H; Ichimiya S; Kanashiro M; Aoyama T; Ogawa Y; Murakami R; Amano T; Naruse K; Matsubara T; Murohara T
Clin Ther; 2006 Nov; 28(11):1812-9. PubMed ID: 17213001
[TBL] [Abstract][Full Text] [Related]
10. Effect of intracoronary adenosine infusion during coronary intervention on myocardial reperfusion injury in patients with acute myocardial infarction.
Claeys MJ; Bosmans J; De Ceuninck M; Beunis A; Vergauwen W; Vorlat A; Vrints CJ
Am J Cardiol; 2004 Jul; 94(1):9-13. PubMed ID: 15219500
[TBL] [Abstract][Full Text] [Related]
11. Rationale and design of the 'MITOCARE' Study: a phase II, multicenter, randomized, double-blind, placebo-controlled study to assess the safety and efficacy of TRO40303 for the reduction of reperfusion injury in patients undergoing percutaneous coronary intervention for acute myocardial infarction.
MITOCARE Study Group
Cardiology; 2012; 123(4):201-7. PubMed ID: 23202613
[TBL] [Abstract][Full Text] [Related]
12. Milrinone and esmolol decrease cardiac damage after resuscitation from prolonged cardiac arrest.
Zoerner F; Lennmyr F; Wiklund L; Martijn C; Semenas E
Acta Anaesthesiol Scand; 2015 Apr; 59(4):465-74. PubMed ID: 25790148
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy comparison of primary percutaneous coronary intervention by drug-coated balloon angioplasty or drug-eluting stenting in acute myocardial infarction patients with de novo coronary lesions].
Zhang DP; Wang LF; Liu Y; Li KB; Xu L; Li WM; Ni ZH; Xia K; Zhang ZY; Yang XC
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):600-607. PubMed ID: 32842271
[No Abstract] [Full Text] [Related]
14. Treatment of ischaemic left ventricular dysfunction with milrinone or dobutamine administered during coronary artery stenosis in the presence of beta blockade in pigs.
Sidi A; Muehlschlegel JD; Kirby DS; Lobato EB
Br J Anaesth; 2006 Dec; 97(6):799-807. PubMed ID: 17035336
[TBL] [Abstract][Full Text] [Related]
15. Trial design and rationale of TY-51924 as a novel Na+/H+ exchanger inhibitor in patients with ST-elevation acute myocardial infarction undergoing percutaneous coronary intervention.
Ishihara M; Asakura M; Kimura K; Nakao K; Hamada C; Hirayama A
J Cardiol; 2014 Jan; 63(1):82-7. PubMed ID: 23860273
[TBL] [Abstract][Full Text] [Related]
16. Esmolol and percutaneous cardiopulmonary bypass enhance myocardial salvage during ischemia in a dog model.
Laub GW; Muralidharan S; Reibman J; Fernandez J; Anderson WA; Gu J; Daloisio C; McGrath LB; Mulligan LJ
J Thorac Cardiovasc Surg; 1996 May; 111(5):1085-91. PubMed ID: 8622306
[TBL] [Abstract][Full Text] [Related]
17. Clinical experience with esmolol, a short-acting beta-adrenergic blocker in cardiac arrhythmias and myocardial ischemia.
Sung RJ; Blanski L; Kirshenbaum J; MacCosbe P; Turlapaty P; Laddu AR
J Clin Pharmacol; 1986 Mar; 26(S1):A15-A26. PubMed ID: 2870082
[TBL] [Abstract][Full Text] [Related]
18. Administration of milrinone before ischemia, in the presence of beta-blockade, to treat metabolic impairment and myocardial stunning in pigs.
Sidi A; Muehlschlegel JD; Kirby DS; Lobato EB
Acta Anaesthesiol Scand; 2008 Mar; 52(3):397-405. PubMed ID: 18269389
[TBL] [Abstract][Full Text] [Related]
19. Carvedilol versus metoprolol in the acute phase of myocardial infarction:
Bonnemeier H; Ortak J; Tölg R; Witt M; Schmidt J; Wiegand UK; Bode F; Schunkert H; Richardt G
Pacing Clin Electrophysiol; 2005 Jan; 28 Suppl 1():S222-6. PubMed ID: 15683501
[TBL] [Abstract][Full Text] [Related]
20. Dose-dependent Effects of Esmolol-epinephrine Combination Therapy in Myocardial Ischemia and Reperfusion Injury.
Oyama Y; Blaskowsky J; Eckle T
Curr Pharm Des; 2019; 25(19):2199-2206. PubMed ID: 31258066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
